$3.5 BnValue of the global medicinal cannabis market in 2017
$25 BnExpected medicinal cannabis market size by 2021
10%Of funds invested into the industry have been activated
24Countries have introduced regulations for medicinal use
10Of these countries are within the European market
x3Expected European market size compared to American
Value of the global medicinal cannabis market in 2017
Expected medicinal cannabis market size by 2021
Of funds invested into the industry have been activated
Countries have introduced regulations for medicinal use
Of these countries are within the European market
Expected European market size compared to American
Why Sanoid Isolates?
The European market is expected to become the largest medicinal cannabis market in the coming years. Sanoid Isolates has obtained the first part of a production license in Spain with cultivation conditions amongst the most favorable in Europe. But beyond cultivation, we are now in the process to be registered as a manufacturer of GMP compliant extracts and isolates with distinct competitive advantages in each step of the value chain.
Experience & Reliability
We are part of the BOTI Holding N.V, a Dutch company with over 25 years in the industry. We've partnered with Phytoplant Research, who contribute a decade of research into cannabis genetics, with PRIMOR, with the cultivation expertise required for a stable and efficient cultivation, and Novagric, who built our high tech nursery and greenhouses.
With Phytoplant being the first with a Research license for medicinal cannabis in Spain and with Sanoid well in the process to become a producer of medicinal cannabis products, we have a valuable advantage and momentum to take a strong position in the medicinal cannabis market.
Quality & Control
By controlling the entire upstream value chain we are able to produce a higher level of quality and complete traceability of our produce, making Sanoid an ideal supplier of the nutraceutical and pharmaceutical industries - with immense growth projections.